Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma

This publication has 27 references indexed in Scilit:

• Advances in biology of multiple myeloma: clinical applications
  Blood, 2004
• The biological role of estrogen receptors α and β in cancer
  Critical Reviews in Oncology/Hematology, 2004
• The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines
  Annals of the New York Academy of Sciences, 2003
• Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
  Journal of Medicinal Chemistry, 2003
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• The Molecular Pharmacology of SERMs
  Trends in Endocrinology & Metabolism, 1999
• Anti-Estrogens Induce Apoptosis of Multiple Myeloma Cells
  Blood, 1998
• ERβ: Identification and characterization of a novel human estrogen receptor
  FEBS Letters, 1996
• RU 58 668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice
  The Journal of Steroid Biochemistry and Molecular Biology, 1994
• Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas
  Journal of Steroid Biochemistry, 1988